Accessibility Menu
Sona Nanotech logo

Sona Nanotech(OTC) SNANF

Market Cap$25.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)+13%
5 Year-14%
1 Year-55%
1 Month-1%
$0.22
+0.27%
+0.00Today
Sona Nanotech last closing stock price
MetricPriceDate
Last closeUSD 0.222026-07-24
Sona Nanotech stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.13%USD 0.232026-07-17
1 month-0.95%USD 0.222026-06-22
3 month-4.68%USD 0.232026-04-24
Year to date-36.96%USD 0.352025-12-31
1 year-55.46%USD 0.492025-07-24
3 year+36.65%USD 0.162023-07-24
5 year-13.62%USD 0.252021-07-23
Since inception+12.53%USD 0.202018-10-10

Sona Nanotech Financials at a Glance

Market Cap

$25.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$2.75M

EPS (TTM)

-$0.02

P/E Ratio

-12.50

Dividend

$0.00

Beta (Volatility)

0.43 (Low)

Price

$0.22

Volume

2,500

Open

$0.22

Previous Close

$0.22

Daily Range

$0.22 - $0.22

52-Week Range

$0.19 - $0.59

Estimated Earnings Date

Sep 24, 2026

SNANF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sona Nanotech

Sona Nanotech Inc. is a life sciences company focused on nanotechnology, specializing in the development and commercialization of gold nanorod products for diagnostic applications. The company offers a range of products, including the Nanotech COVID-19 Lateral Flow Assay, which detects SARS-CoV-2 antigens in saliva samples.

Products and Services
  • Gold nanorod products for diagnostic purposes
  • Nanotech COVID-19 Lateral Flow Assay for rapid testing
  • Specialized contract services for various applications
Growth Outlook
  • Expansion into diverse applications, including drug delivery and cancer treatment
  • Increasing demand for rapid diagnostic tests in healthcare
  • Potential partnerships to enhance product offerings and market reach
Financial Highlights
  • Recent quarterly revenue of $0, indicating a focus on R&D and product development
  • Trailing twelve months (TTM) net income of -$2.8 million, reflecting ongoing investment in growth
  • Cash and short-term investments of $52,740, supporting operational needs
Sona Nanotech Inc. operates in the medical diagnostics and research sector, leveraging advanced nanotechnology to create innovative solutions. The company's flagship product, the Nanotech COVID-19 Lateral Flow Assay, exemplifies its commitment to addressing urgent healthcare needs. Despite recent financial challenges, the focus on research and development positions Sona Nanotech for potential growth as the demand for rapid diagnostics and advanced medical technologies continues to rise. The company’s strategic initiatives and product diversification may attract interest from investors looking for opportunities in the evolving healthcare landscape.
AI Generated • Jul 25, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

8

CEO

David Andrew Regan, MBA

Website

www.sonanano.com

Headquarters

Halifax, NS B3J 3R7, CA

SNANF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

1894.66%

Return on Capital

-1279.84%

Return on Assets

-364.97%

Earnings Yield

-8.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$25.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

114.38M

Volume

2.50K

Avg. Volume

8.72K

Financials (TTM)

Gross Profit

-CA$1.21M

Operating Income

-CA$3.13M

EBITDA

-CA$2.24M

Operating Cash Flow

-CA$2.08M

Capital Expenditure

CA$4.20

Free Cash Flow

-CA$2.08M

Cash & ST Invst.

CA$52.74K

Total Debt

CA$328.76K

Sona Nanotech Performance Analysis

Sona Nanotech annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-10-31CAD 0N/A
20232023-10-31CAD 0N/A
20242024-10-31CAD 0N/A
20252025-10-31CAD 0N/A
Sona Nanotech sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-31N/A
Q42025-10-31N/A
Q12026-01-31N/A
Q22026-04-30N/A
Sona Nanotech annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-10-31CAD -0.03-79.2%
20232023-10-31CAD -0.02-19.4%
20242024-10-31CAD -0.02-8.3%
20252025-10-31CAD -0.024.5%
Sona Nanotech sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-31-28.2%
Q42025-10-3151.0%
Q12026-01-31-20.4%
Q22026-04-308.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$179.94K

-38.0%

Gross Margin

0.00%

N/A

Market Cap

$25.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.15M

N/A

Employees

8

N/A

Net Income

-CA$633.32K

+27.9%

EBITDA

-CA$439.76K

+35.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$52.74K

-92.8%

Total Debt

CA$328.76K

-22.1%

Accounts Receivable

CA$5.65K

-96.7%

Inventory

CA$0.00

N/A

Long Term Debt

CA$328.76K

-22.1%

Short Term Debt

CA$0.00

N/A

Return on Assets

-3.65%

N/A

Return on Invested Capital

7.20%

N/A

Free Cash Flow

-CA$537.68K

-28.8%

Operating Cash Flow

-CA$537.68K

-28.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ETSTEarth Science Tech, Inc.
$0.11-10.83%
ZIVOZIVO Bioscience, Inc.
$5.00+0.00%
ACHFFArch Biopartners Inc.
$0.58+4.90%
PLNHPlanet 13 Holdings Inc.
$0.12-0.91%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.67-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.24-0.02%
TAT&T
$24.42+0.01%

Questions About SNANF

What is the current price of Sona Nanotech?

Sona Nanotech is trading at $0.22 per share.

What is the 52-week range for Sona Nanotech?

Over the past 52 weeks, Sona Nanotech has traded between $0.19 and $0.59.

How much debt does Sona Nanotech have?

As of the most recent reporting period, Sona Nanotech reported total debt of CA$241.62K.

How much cash does Sona Nanotech have on hand?

Sona Nanotech reported CA$35.82K in cash and cash equivalents in its most recent financial results.

What is Sona Nanotech’s dividend yield?

Sona Nanotech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services